Acura Pharmaceuticals Receives $200,000 Financing Advance
Acura Pharmaceuticals received two additional $100,000 advances from Abuse Deterrent Pharma on September 18 and October 2, 2026, to fund operations. These advances bring the principal under the November 10, 2022 secured promissory note to $11,294,279.